Honorable John T. Smithee, Chair, House Committee on Insurance
FROM:
John S. O'Brien, Director, Legislative Budget Board
IN RE:
HB4402 by Martinez Fischer (Relating to a study regarding insurance coverage of prescription drugs provided under a health benefit plan.), Committee Report 1st House, Substituted
No significant fiscal implication to the State is anticipated.
The bill would amend the Insurance Code to require the Texas Department of Insurance (TDI) to conduct a study to evaluate the ways in which pharmacy benefit managers use prescription drug information. The bill would require TDI to create a report with the findings of the study to be submitted no later than August 1, 2010. The agency indicates there would be some cost to implement the provisions of the bill, but these costs are expected to be absorbed within the agency's existing budget.
Local Government Impact
No fiscal implication to units of local government is anticipated.